Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Scientists describe CFTR inhibitors for acute secretory diarrhea

Sep. 30, 2010

Clinical data presented on DiaPep-277 in type 1 diabetes

Sep. 30, 2010

Studies point to potential benefit of ITI-007 in Parkinson's disease

Sep. 29, 2010

SUN-13834 is efficacious in patients with atopic dermatitis

Sep. 29, 2010

CYT-003-QbG-10 is safe and efficacious in allergic asthma

Sep. 29, 2010

Phase I data presented on flu vaccine NB-1008 and acne therapy NB-003

Sep. 29, 2010

Imeglimin shows promise in phase II trials in type 2 diabetes

Sep. 29, 2010

Phase II data on MK-0941 cast doubt on suitability for treatment of diabetes

Sep. 29, 2010

Namisol tablet for multiple sclerosis shows promise in first-in-human trial

Sep. 28, 2010

E-6005 improves pruritus and inflammation in preclinical tests

Sep. 28, 2010

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...